Omicron Variant Is Boosting This Leveraged Biotech ETF
December 15, 2021 at 16:42 PM EST
The Omicron variant re-asserted the strength of biotech equities, making the Direxion Daily S&P Biotech Bull 3x Shares (LABU) an option for traders. As investors turned up the risk dial, COVID-19 cases ticked up towards the end of the year, and now with the new variant, they can provide an...